Resumen
The invention relates to a composition comprising galactomannan in an amount ranged from 36 to 40% w/w, fructooligossacharides in an amount of 2 to 4% (w/w) and at least one extract of polar nature containing bioactive compounds, with a concentration between 30 and 49% in the composition. The invention also relates to the uses of said composition for the administration of said bioactive compounds contained in the extract, protecting from their degradation during the physiological digestion.
Reivindicaciones
CLAIMS 1. A composition comprising: galactomannan in an amount of from 36 to 40% by weight based on the total weight of the composition, fructooligossacharides in an amount of from 2 to 4% by weight based on the total weight of the composition, and at least one extract of polar nature. 2. Composition according to claim 1 , wherein the amount of galactomannan is 36% by weight based on the total weight of the composition and/or the amount of fructooligosascharides is 3% by weight based on the total weight of the composition. 3. Composition according to claim 1 or 2, wherein galactomannan comprise a mannose:galactose ratio of 3:1. 4. Composition according to any one of claims 1 to 3, wherein the fructooligossacharides comprise no less than 90% by weight of oligofructose (%, dry matter). 5. Composition according to any one of claims 1 to 4, wherein the extract of polar nature comprises hydrolysable tannins derived from gallic acid. 6. Composition according to claim 5, wherein the hydrolysable tannins derived from gallic acid represent between 50 to 90% by weight of the extract of polar nature, preferably 70 % by weight. 7. Composition according to any one of claims 1 to 6, wherein the extract of polar nature is derived from carob, preferably from carob pods. 8. Composition according to any one of claims 1 to 7, wherein the extract of polar nature is in an amount of from 30 to 49% by weight based on the total weight of the composition, preferably 40% by weight. 9. Composition according to any one of claims 1 to 8 for use as a medicament. 10. Composition according to any one of claims 1 to 8 for use in the treatment and/or prevention of a pathological condition associated to the metabolic syndrome. 1 1. Composition for use according to claim 10 wherein the pathological condition is selected from obesity, endothelial dysfunction, dyslipidaemia, hypertension and hyperglycaemia. 12. A composition for use in increasing the absorption of an extract of polar nature in a subject with the following composition: galactomannans in an amount of from 36 to 40% by weight based on the total weight of the composition, fructooligossacharides in an amount of from 2 to 4% by weight based on the total weight of the composition, and said extract of polar nature. 13. Composition for use according to claim 12, wherein the amount of galactomanans is 36% by weight based on the total weight of the composition and/or the amount of fructooligossacharides is 3% by weight based on the total weight of the composition. 14. Composition for use according to claim 12 or 13, wherein the galactomannans comprise a mannose:galactose ratio of 3:1. 15. Composition for use according to any one of claims 12 to 14, wherein the fructooligossacharides comprise no less than 90% by weight of oligofructose (%, dry matter). 16. Composition for use according to any one of claims 12 to 15, wherein the extract of polar nature comprises hydrolysable tannins derived from gallic acid. 17. Composition for use according to claim 16, wherein the hydrolysable tannins derived from gallic acid represent between 50 to 90% by weight of the extract of polar nature, preferably 70% by weight. 18. Composition for use according to any one of claims 12 to 17, wherein the extract of polar nature is derived from carob, preferably from carob pods. 19. Composition for use according to any one of claims 12 to 18, wherein the extract of polar nature is in an amount of from 30 to 49% by weight based on the total weight of the composition, preferably 40% by weight.
